Ginsenoside Rh2 reduces m6A RNA methylation in cancer via the KIF26B-SRF positive feedback loop
Open Access
- 25 May 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 45 (6), 734-743
- https://doi.org/10.1016/j.jgr.2021.05.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancerJournal of Experimental & Clinical Cancer Research, 2015
- SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancerCell Death & Differentiation, 2014
- Gene Expression Profiling in Leiomyosarcomas and Undifferentiated Pleomorphic Sarcomas: SRC as a New Diagnostic MarkerPLOS ONE, 2014
- GeneMANIA: Fast gene network construction and function prediction for CytoscapeF1000Research, 2014
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferaseCell Research, 2014
- N6-methyladenosine-dependent regulation of messenger RNA stabilityNature, 2013
- Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53Cancer Letters, 2011
- Kif26b , a kinesin family gene, regulates adhesion of the embryonic kidney mesenchymeProceedings of the National Academy of Sciences of the United States of America, 2010
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- Ginsenoside Rh2-mediated G1 Phase Cell Cycle Arrest in Human Breast Cancer Cells Is Caused by p15 Ink4B and p27 Kip1 -dependent Inhibition of Cyclin-dependent KinasesPharmaceutical Research, 2009